BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instability

BRCA2 plays a critical role in stabilizing stalled replication forks, yet critical gaps remain in understanding how BRCA2 deficiency triggers fork collapse and drives genomic instability. Here, we identify cytidine deaminase APOBEC3B as a key driver of this process. Using a unique uracil-in-DNA probe, we show that BRCA2 loss promotes APOBEC3B-mediated uracil accumulation in single-stranded DNA (U-ssDNA) at stalled forks. These lesions when processed by UNG2 and APE1, trigger fork collapse and release ssDNA fragments into the cytoplasm, activating NF-κB signaling. This in turn upregulates APOBEC3B expression, establishing a self-reinforcing loop that amplifies cytidine deamination at stalled forks and exacerbates genomic instability. Depletion of APOBEC3B, UNG2, or APE1 rescues these defects. Notably, BRCA1-deficient cells do not accumulate U-ssDNA or induce APOBEC3B under replication stress, highlighting a BRCA2-specific vulnerability. Clinically, low APE1 expression correlates with poor survival in patients with BRCA2-mutant tumors, with high APOBEC3 levels further worsening outcomes. Together, our findings establish that replication stress, whether intrinsic or therapy induced, triggers APOBEC3B overexpression and potentially activates an APOBEC3B-driven mutagenic loop in BRCA2-deficient cells. These results position APOBEC3B, UNG2 and APE1 as critical regulators of BRCA2-mutant tumor evolution and therapy resistance.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-10-29
DOI
https://doi.org/10.1038/s41467-025-64578-6
Citations
1
Primary Topic
DNA Repair Mechanisms
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instability

Shailja Pathania, Beáta G. Vértessy, Charles Swanton, Stephen K. Godin et al.
1 citations
Nature Communications
DNA Repair Mechanisms
0.81
article

BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instability

Shailja Pathania, Beáta G. Vértessy, Charles Swanton, Stephen K. Godin, Abby M. Green, Subramanian Venkatesan, Haohui Duan, Joshua Yang, Nisha Patel, Jie Chen, Kathy Situ, Nicolai J. Birkbak, Margaret K. Gillis, Hajnalka L. Pálinkás, Pratha Rawal, Silvi Salhotra, Salome K. Mouliere, Gabrielle Q. McCloskey, Basim Naeem, Muhammad H. Zeb
article en
1 citations

Abstract

BRCA2 plays a critical role in stabilizing stalled replication forks, yet critical gaps remain in understanding how BRCA2 deficiency triggers fork collapse and drives genomic instability. Here, we identify cytidine deaminase APOBEC3B as a key driver of this process. Using a unique uracil-in-DNA probe, we show that BRCA2 loss promotes APOBEC3B-mediated uracil accumulation in single-stranded DNA (U-ssDNA) at stalled forks. These lesions when processed by UNG2 and APE1, trigger fork collapse and release ssDNA fragments into the cytoplasm, activating NF-κB signaling. This in turn upregulates APOBEC3B expression, establishing a self-reinforcing loop that amplifies cytidine deamination at stalled forks and exacerbates genomic instability. Depletion of APOBEC3B, UNG2, or APE1 rescues these defects. Notably, BRCA1-deficient cells do not accumulate U-ssDNA or induce APOBEC3B under replication stress, highlighting a BRCA2-specific vulnerability. Clinically, low APE1 expression correlates with poor survival in patients with BRCA2-mutant tumors, with high APOBEC3 levels further worsening outcomes. Together, our findings establish that replication stress, whether intrinsic or therapy induced, triggers APOBEC3B overexpression and potentially activates an APOBEC3B-driven mutagenic loop in BRCA2-deficient cells. These results position APOBEC3B, UNG2 and APE1 as critical regulators of BRCA2-mutant tumor evolution and therapy resistance.

Nature CommunicationsVol. 16(1)
Aarhus University (DK), Washington University in St. Louis (US), The Francis Crick Institute (GB), Royal London Hospital (GB), Cancer Research UK (GB), Aarhus University Hospital (DK), Budapest University of Technology and Economics (HU), University of Massachusetts Boston (US), London Cancer (GB), CRUK Lung Cancer Centre of Excellence (GB), University College London (GB), HUN-REN Research Centre for Natural Sciences (HU)
U.S. Department of Defense, Breast Cancer Research Foundation, Yale University, Norges Teknisk-Naturvitenskapelige Universitet, Wellcome Trust, Francis Crick Institute, Mark Foundation For Cancer Research, Cancer Research UK, National Institute for Health and Care Research, University College London, European Commission, Rosetrees Trust, Magyar Tudományos Akadémia, Università degli Studi di Udine, Innovációs és Technológiai Minisztérium, National Institutes of Health, Medical Research Council, Nemzeti Kutatási, Fejlesztési és Innovaciós Alap, National Research, Development and Innovation Office
Openalex Percentile: Top 22%
DNA Repair Mechanisms
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.